Please login (Members) to view content or
(Nonmembers) this article.
0
No votes yet
Genetics & Genomics

Cowden Syndrome: What Oncology Nurses Need to Know About Increased Risk of Developing Certain Cancers

Laura Curr Beamer
ONF 2014, 41(5), 555-557 DOI: 10.1188/14.ONF.555-557

Cowden syndrome (CS) is a genetic disorder characterized by multiple benign tissue growths (i.e., hamartomas) and an increased risk of developing specific cancers, such as breast, thyroid, kidney, endometrial, or colorectal cancer (Genetics Home Reference, 2012). This genetic syndrome was named after a person diagnosed with the disorder (Lloyd & Dennis, 1963). CS is part of a larger syndrome called PTEN hamartomatous syndrome, which also includes Bannayan-Riley-Ruvalcaba syndrome, PTEN-related Proteus syndrome, and Proteus-like syndrome (Eng, 2014).

Members Only

Access to this article is restricted. Please login to view the full article.

Not a current ONS Member or journal subscriber?
Join/Renew Membership or